The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Detection and characterization of the heterozygote state for lipoprotein lipase deficiency.
Open accessAbstract
Because there are no characteristic clinical or biochemical manifestations, the heterozygote state for lipoprotein lipase (LPL) deficiency has been difficult to detect. Measurements of postheparin plasma LPL activity and of LPL mass were performed in six families of probands with LPL deficiency to characterize the heterozygote state. LPL mass was measured in a sandwich enzyme-linked immunosorbent assay (ELISA) using a monoclonal antibody (5D2) that had been produced against bovine milk LPL. Thirteen obligate heterozygotes from these families had reduced LPL activity and mass below the 95th percent confidence limits of 34 normal controls, while one obligate heterozygote had LPL activity and mass between the 90th and 95th percent confidence limits. Potential heterozygotes in these families were identified as normal (n = 8) or heterozygotes (n = 6) by comparison to the 95th percent confidence limits of the controls. Some relatives in four of the six families exhibited mild hyperlipidemia, similar to the pattern seen in familial combined hyperlipidemia (FCHL). The hyperlipidemia segregated with the heterozygote state for LPL deficiency in these families (p less than 0.03). High density lipoprotein (HDL) cholesterol was significantly reduced in the heterozygotes for LPL deficiency (p less than 0.01). The measurement of LPL activity and mass allows identification of the heterozygote state for LPL deficiency, which is characterized by variable expressions of hyperlipidemia and reduced HDL cholesterol. These results suggest that the heterozygote state for LPL deficiency may form one subset of FCHL.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Production of monoclonal antibodies: Strategy and tactics
de St. Groth, S. F., & Scheidegger, D. (1980) · Journal of Immunological Methods · doi:10.1016/0022-1759(80)90146-5 · Cited by 1,576
Goldstein, J. L., Schrott, H. G., Hazzard, W. R., Bierman, E. L., & Motulsky, A. G. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107332 · Cited by 1,443
[28] Enzyme immunoassay ELISA and EMIT
Engvall, E. (1980) · Methods in Enzymology · doi:10.1016/s0076-6879(80)70067-8 · Cited by 1,005
The isolation of IgG from mammalian sera with the aid of caprylic acid
Steinbuch, M., & Audran, R. (1969) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(69)90285-9 · Cited by 860
IDIOPATHIC HYPERLIPEMIA: METABOLIC STUDIES IN AN AFFECTED FAMILY*
Havel, R. J., & Gordon, R. S. (1960) · Journal of Clinical Investigation · doi:10.1172/jci104202 · Cited by 380
Iverius, P. H., & Ostlund-Lindqvist, A. M. (1976) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)57004-1 · Cited by 227
Self-citationScow, R. O., Blanchette-Mackie, E. J., & Smith, L. C. (1976) · Circulation Research · doi:10.1161/01.res.39.2.149 · Cited by 218
Immunoassay of human plasma apolipoprotein B
Albers, J. J., Cabana, V. G., & Hazzard, W. R. (1975) · Metabolism · doi:10.1016/0026-0495(75)90050-5 · Cited by 181
MAGILL, P., Rao, S. N., Miller, N. E., Nicoll, A., Brunzell, J., Hilaire, J., & Lewis, B. (1982) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1982.tb00947.x · Cited by 122
Self-citationHarlan, W. R., Winesett, P. S., & Wasserman, A. J. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105526 · Cited by 101
Cited by
Hegele, R. A., Ginsberg, H. N., Chapman, M. J., Nordestgaard, B. G., Kuivenhoven, J. A., Averna, M., Borén, J., Bruckert, E., Catapano, A. L., Descamps, O. S., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70191-8 · Cited by 635
Beisiegel, U., Weber, W., & Bengtsson-Olivecrona, G. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8342 · Cited by 468
Benlian, P., De Gennes, J. L., Foubert, L., Zhang, H., Gagné, S. E., & Hayden, M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199609193351203 · Cited by 297
Zambon, A., Hokanson, J. E., Brown, B. G., & Brunzell, J. D. (1999) · Circulation · doi:10.1161/01.cir.99.15.1959 · Cited by 263
Self-citationInheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia.
Austin, M. A., Brunzell, J. D., Fitch, W. L., & Krauss, R. M. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.4.520 · Cited by 262
Self-citationGenetics of hypertriglyceridemia
Dron, J. S., & Hegele, R. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00455 · Cited by 244
Severe hypertriglyceridemia is primarily polygenic
Dron, J. S., Wang, J., Cao, H., McIntyre, A. D., Iacocca, M. A., Menard, J. R., Movsesyan, I., Malloy, M. J., Pullinger, C. R., Kane, J. P., et al. (2019) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2018.10.006 · Cited by 222
Williams, K. J., Fless, G. M., Petrie, K. A., Snyder, M. L., Brocia, R. W., & Swenson, T. L. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42208-9 · Cited by 205
Lipoprotein Lipase S447X: A Naturally Occurring Gain-of-Function Mutation
Rip, J., Nierman, M. C., Ross, C. J., Jukema, J. W., Hayden, M. R., Kastelein, J. J. P., Stroes, E. S. G., & Kuivenhoven, J. A. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000219283.10832.43 · Cited by 157
Nordestgaard, B. G., Abildgaard, S., Wittrup, H. H., Steffensen, R., Jensen, G., & Tybjærg-Hansen, A. (1997) · Circulation · doi:10.1161/01.cir.96.6.1737 · Cited by 146
Wang, H., Astarita, G., Taussig, M. D., Bharadwaj, K. G., DiPatrizio, N. V., Nave, K.-A., Piomelli, D., Goldberg, I. J., & Eckel, R. H. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2010.12.006 · Cited by 139
“And although humans with homozygous LPL deficiency are typically not obese, patients with heterozygous LPL deficiency can be overweight or obese (Babirak et al., 1989; Julien et al., 1997).”
BackgroundGenetic Mutations Affecting Human Lipoproteins, Their Receptors, and Their Enzymes
Zannis, V. I., Kardassis, D., & Zanni, E. E. (1993) · Advances in Human Genetics 21 · doi:10.1007/978-1-4615-3010-7_3 · Cited by 78
Reina, M., Brunzell, J., & Deeb, S. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41340-9 · Cited by 74
Self-citationKristensen, K. K., Leth-Espensen, K. Z., Mertens, H. D. T., Birrane, G., Meiyappan, M., Olivecrona, G., Jørgensen, T. J. D., Young, S. G., & Ploug, M. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1920202117 · Cited by 72
Combined hyperlipidemia: familial but not (usually) monogenic
Brahm, A. J., & Hegele, R. A. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000270 · Cited by 71
Successful hyperlipemic pregnancy.
Sanderson, S. L. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03460140086032 · Cited by 57
Delayed post-prandial lipid metabolism in subjects with intra-abdominal visceral fat accumulation
Taira, Hikita, Kobayashi, Bujo, Takahashi, Murano, Morisaki, & Saito (1999) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1999.00454.x · Cited by 47
van Barlingen, H. H. J. J., Kock, L. A. W., de Man, F. H. A. F., Erkelens, D. W., & de Bruin, T. W. A. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05703-x · Cited by 22
Liu, G., Excoffon, K. J. D. A., Benoit, P., Ginzinger, D. G., Miao, L., Ehrenborg, E., Duverger, N., Denefle, P. P., Hayden, M. R., & Lewis, M. E. S. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.2-205 · Cited by 9
Metadata
- Authors
- Babirak, S. P., Iverius, P. H., Fujimoto, W. Y., & Brunzell, J. D.
- Venue
- Arteriosclerosis: An Official Journal of the American Heart Association, Inc.
- Published
- 1989-05
- Volume
- 9
- Issue
- 3
- Pages
- 326-334
- ISSN
- 0276-5047 (ISSN-L)
- OpenAlex
- W2014670571
- Cited by
- 293
- References
- 27
- FWCI
- 24.51
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.